- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease and Allied Conditions in Norway
Total 5729 results
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Canada, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD) With CachexiaUnited States, United Kingdom, Netherlands
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, United Kingdom, China, Philippines, Italy, Taiwan, Puerto Rico, Israel, Thailand, Peru, Colombia, Poland, Brazil, Germany, Russian Federation, Romania, France, Chile, Greece
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Norwegian University of Science and TechnologyThe Research Council of NorwayCompletedHeart Failure | Stroke | Chronic Obstructive Pulmonary DiseaseNorway
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, New Zealand, Belgium
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Belgium, Australia, Israel, Spain, France, United Kingdom, Denmark, Argentina, Germany, New Zealand, South Africa, Korea, Republic of, Poland, Bulgaria, Canada, Chile, Czechia, Netherlands, Romania, Sweden, Mexico
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveDenmark, Netherlands, Finland, Belgium, Germany, Norway
-
Genentech, Inc.Active, not recruitingChronic Obstructive Pulmonary DiseaseUnited States, Israel, Australia, Denmark, Korea, Republic of, Spain, Belgium, France, Bulgaria, Poland, United Kingdom, Germany, Canada, Netherlands, Peru, Argentina, Hong Kong, South Africa, New Zealand, Sweden, Czechia, Chile, Ro... and more
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Pearl Therapeutics, Inc.Completed
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Colombia, Poland, South Africa, Canada, Estonia, Hungary, India, Austria, Israel, Netherlands, United Kingdom, Argentina, France, Italy, Spain, Czech Republic, Denmark, Finland, Greece, Ireland, Mexico, Peru, Phi... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, France, Italy, Spain, Turkey, United Kingdom, Germany, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Greece, Ireland, Switzerland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Germany, Estonia, Ukraine, Korea, Republic of, Norway, Czechia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Poland, South Africa, Netherlands
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
NovartisCompletedCOPDUnited States, Argentina, Germany, Spain, Canada, India, Turkey, Sweden, Italy
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Germany, Spain, Turkey, Hungary, Czech Republic, India, Slovakia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of, Turkey, United States, Chile, Czechia, Israel, Russian Federation, Argentina, Brazil, Bulgaria, Canada, Denmark, Estonia, France, Georgia, Germany, Hungary, India, Japan, Latvia, Lithuania, Mexico, Netherlands, Norway and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
MedImmune LLCAstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Poland, Spain, United Kingdom, Denmark, Canada, Germany
-
United TherapeuticsTerminatedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States, Israel, Argentina, Puerto Rico
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | Chronic BronchitisUnited States
-
Teva Pharmaceuticals EuropeCompletedChronic Obstructive Pulmonary Disease | AsthmaCroatia, Denmark, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom
-
SanofiRegeneron PharmaceuticalsActive, not recruitingChronic Obstructive Pulmonary DiseaseGreece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseBulgaria, United States, Argentina, Austria, Bosnia and Herzegovina, Chile, Croatia, Czechia, Estonia, Germany, Greece, Hungary, Israel, Latvia, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian Federation and more
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Romania, Russian Federation, Chile, Sweden, Spain, Hungary, Czechia, Norway
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Costa Rica, Brazil, Chile, Mexico, Argentina
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Croatia, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, South Africa, Spain, Sweden, Thailand, Ukraine
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, Romania, Russian Federation, South Africa, Spain, Sweden, Thailand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
The Hospital of VestfoldSensocure ASNot yet recruitingPulmonary Disease, Chronic Obstructive | Neuromuscular Diseases | Hypercapnic Respiratory Failure | Obesity Hypoventilation Syndrome (OHS)Norway
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Romania, Italy, Spain, Belgium, Denmark, Estonia, Sweden, Austria, Latvia, United Kingdom, Ukraine, Russian Federation, Greece, Czech Republic, Slovenia, Norway, Lithuania, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructivePuerto Rico, United States, Australia, Argentina, France, Germany, Japan, Netherlands, Russian Federation, Spain, Ukraine, Finland, Czechia, Poland, Belgium, Chile, Peru, South Africa, Sweden, Thailand, Israel, Korea, Republic of, C... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Mexico, Norway
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
PfizerTerminatedDiabetes Mellitus | Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Brazil, Costa Rica, Germany